Evidence map›Paper›PMID 27655734›Full record

ArticleNeurology2016

Cognitive decline following incident and preexisting diabetes mellitus in a population sample.

Kumar B Rajan, Zoe Arvanitakis, Elizabeth B Lynch, Elizabeth A McAninch, Robert S Wilson, Jennifer Weuve, Lisa L Barnes, Antonio C Bianco, Denis A Evans

Open access · bronzeAbstract read
In one paragraph

Article in Neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Diabetes-Specific Dementia: A Structured Literature Review of Cognitive Assessment Methods.The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Cardiovascular and metabolic morbidity following spinal cord injury.The spine journal : official journal of the North American Spine Society · 2021
    Article
  6. Article
  7. The Relation of Diabetes to Memory Function.Current neurology and neuroscience reports · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Associations of literacy with diabetes indicators in older adults.Journal of epidemiology and community health · 2019
    Article
  14. Article
  15. Article
  16. Changes of glucose levels precede dementia in African-Americans with diabetes but not in Caucasians.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2018
    Article
  17. Article
  18. Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kumar B RajanFrom the Rush Institute for Healthy Aging (K.B.R., J.W., D.A.E.), Rush Alzheimer's Disease Center (Z.A., R.S.W., L.L.B.), Departments of Neurological Sciences (Z.A., R.S.W., L.L.B.) and Preventive Medicine (E.B.L.), and Division of Endocrinology and Metabolism (E.A.M., A.C.B.), Rush University Medical Center, Chicago, IL. kumar_rajan@rush.edu.
Zoe ArvanitakisFrom the Rush Institute for Healthy Aging (K.B.R., J.W., D.A.E.), Rush Alzheimer's Disease Center (Z.A., R.S.W., L.L.B.), Departments of Neurological Sciences (Z.A., R.S.W., L.L.B.) and Preventive Medicine (E.B.L.), and Division of Endocrinology and Metabolism (E.A.M., A.C.B.), Rush University Medical Center, Chicago, IL.
Elizabeth B LynchFrom the Rush Institute for Healthy Aging (K.B.R., J.W., D.A.E.), Rush Alzheimer's Disease Center (Z.A., R.S.W., L.L.B.), Departments of Neurological Sciences (Z.A., R.S.W., L.L.B.) and Preventive Medicine (E.B.L.), and Division of Endocrinology and Metabolism (E.A.M., A.C.B.), Rush University Medical Center, Chicago, IL.
Elizabeth A McAninchFrom the Rush Institute for Healthy Aging (K.B.R., J.W., D.A.E.), Rush Alzheimer's Disease Center (Z.A., R.S.W., L.L.B.), Departments of Neurological Sciences (Z.A., R.S.W., L.L.B.) and Preventive Medicine (E.B.L.), and Division of Endocrinology and Metabolism (E.A.M., A.C.B.), Rush University Medical Center, Chicago, IL.
Robert S WilsonFrom the Rush Institute for Healthy Aging (K.B.R., J.W., D.A.E.), Rush Alzheimer's Disease Center (Z.A., R.S.W., L.L.B.), Departments of Neurological Sciences (Z.A., R.S.W., L.L.B.) and Preventive Medicine (E.B.L.), and Division of Endocrinology and Metabolism (E.A.M., A.C.B.), Rush University Medical Center, Chicago, IL.
Jennifer WeuveFrom the Rush Institute for Healthy Aging (K.B.R., J.W., D.A.E.), Rush Alzheimer's Disease Center (Z.A., R.S.W., L.L.B.), Departments of Neurological Sciences (Z.A., R.S.W., L.L.B.) and Preventive Medicine (E.B.L.), and Division of Endocrinology and Metabolism (E.A.M., A.C.B.), Rush University Medical Center, Chicago, IL.
Lisa L BarnesFrom the Rush Institute for Healthy Aging (K.B.R., J.W., D.A.E.), Rush Alzheimer's Disease Center (Z.A., R.S.W., L.L.B.), Departments of Neurological Sciences (Z.A., R.S.W., L.L.B.) and Preventive Medicine (E.B.L.), and Division of Endocrinology and Metabolism (E.A.M., A.C.B.), Rush University Medical Center, Chicago, IL.
Antonio C BiancoFrom the Rush Institute for Healthy Aging (K.B.R., J.W., D.A.E.), Rush Alzheimer's Disease Center (Z.A., R.S.W., L.L.B.), Departments of Neurological Sciences (Z.A., R.S.W., L.L.B.) and Preventive Medicine (E.B.L.), and Division of Endocrinology and Metabolism (E.A.M., A.C.B.), Rush University Medical Center, Chicago, IL.
Denis A EvansFrom the Rush Institute for Healthy Aging (K.B.R., J.W., D.A.E.), Rush Alzheimer's Disease Center (Z.A., R.S.W., L.L.B.), Departments of Neurological Sciences (Z.A., R.S.W., L.L.B.) and Preventive Medicine (E.B.L.), and Division of Endocrinology and Metabolism (E.A.M., A.C.B.), Rush University Medical Center, Chicago, IL.
Rush University Medical Center · US

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
Risk Factors for Incident Alzheimer's Disease in a Biracial CommunityR01AG011101 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI EVANS, DENIS A · 1993 to 2010
$24.7M
Risk Factors for Cognitive Decline in African-AmericansR01AG022018 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BARNES, LISA L · 2004 to 2025
$18.2M
Characterizing the Behavior Profile of Healthy Cognitive AgingR01AG034374 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI PATRICIA A BOYLE · 2009 to 2026
$8.8M
Genetic Epidemiology of Cognitive Decline in an Aging Population SampleR01AG030146 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI EVANS, DENIS A · 2007 to 2018
$6.2M
Rush Center of Excellence on Disparties in HIV and Aging (CEDHA)P20MD006886 · NIMHD · RUSH UNIVERSITY MEDICAL CENTER · PI SHAH, RAJ C · 2012 to 2016
$6.0M
Risk Factors, Pathology, and Clinical Expressions of ADRF1AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2014 to 2014
$6.0M
EPIDEMIOLOGIC STUDY OF PERSONS WITH ALZHEIMERS DISEASER01AG009966 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI EVANS, DENIS A · 1991 to 2009
$5.4M
Metabolic and Xenobiotic Control of Thyroid Hormone MetabolismR01DK077148 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI ANTONIO C BIANCO · 2007 to 2026
$4.5M
Thyroid-adrenergic synergism and adaptive thermogenesisR01DK065055 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BIANCO, ANTONIO C · 2005 to 2021
$4.4M
Epidemiology of Familial Late-Onset Alzheimer's DiseaseR01AG041797 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAYEUX, RICHARD P · 2012 to 2016
$4.2M
NCCIH NIH HHS R01 AT007143NCCIH NIH HHS R34 AT008347NIA NIH HHS P30 AG010161NIA NIH HHS R01 AG009966NIA NIH HHS R01 AG011101NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG022018NIA NIH HHS R01 AG030146NIA NIH HHS R01 AG034374NIA NIH HHS R01 AG036042NIA NIH HHS R01 AG036836NIA NIH HHS R01 AG039478NIA NIH HHS R01 AG040039NIA NIH HHS R01 AG041797NIA NIH HHS R01 AG042210NIA NIH HHS R01 AG042318NIA NIH HHS R01 AG051635NIA NIH HHS RF1 AG015819NIDA NIH HHS R01 DA039522NIDDK NIH HHS R01 DK065055NIDDK NIH HHS R01 DK077148NIDDK NIH HHS R01 DK092271NIEHS NIH HHS R21 ES020404NIMHD NIH HHS P20 MD006886NIMHD NIH HHS R01 MD006173NIMH NIH HHS R34 MH100443NINDS NIH HHS R01 NS084965NINR NIH HHS R01 NR013151NINR NIH HHS R01 NR014846
6 · The paper itself

Abstract

objectiveTo examine if incident and preexisting diabetes mellitus (DM) were associated with cognitive decline among African Americans (AAs) and European Americans (EAs).

methodsBased on a prospective study of 7,740 older adults (mean age 72.3 years, 64% AA, 63% female), DM was ascertained by hypoglycemic medication use and Medicare claims during physician or hospital visits, and cognition by performance on a brief battery for executive functioning, episodic memory, and Mini-Mental State Examination (MMSE). Decline in composite and individual tests among those with incident DM, with preexisting DM, and without DM was studied using a linear mixed effects model with and without change point.

resultsAt baseline, 737 (15%) AAs and 269 (10%) EAs had preexisting DM. Another 721 (17%) AAs and 289 (12%) EAs had incident DM in old age. Following incident DM, cognitive decline increased by 36% among AAs and by 40% among EAs compared to those without DM. No significant difference was observed between AAs and EAs (p = 0.64). However, cognitive decline increased by 17% among AAs with preexisting DM compared to those without DM, but no increased decline was observed among EAs with preexisting DM. In secondary analyses, faster decline in executive functioning and episodic memory was observed following incident DM.

conclusionsIn old age, faster cognitive decline was present among AAs and EAs following incident DM, compared to cognitive decline prior to DM, and among those without DM. This underscores the need for stronger prevention and control of DM in old age.

Indexed as

AgedBlack or African AmericanChicagoCognitionCognitive DysfunctionDiabetes ComplicationsDiabetes Mellitus, Type 2Disease ProgressionFemaleFollow-Up StudiesHumansHypoglycemic AgentsIncidenceLinear ModelsLongitudinal StudiesMaleHypoglycemic Agents

Identifiers

PMID27655734
PMCPMC5085078
OpenAlexW2522639580

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.